Related Experiment Video
Updated: Jul 14, 2026
12:28
Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
Published on: June 3, 2020
Frontotemporal dementia with tau pathology.
Laura Gasparini1, Beatrice Terni, Maria Grazia Spillantini
1Cambridge Centre for Brain Repair, Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.
Neuro-Degenerative Diseases
|June 29, 2007
Summary
Tau protein dysfunction causes neurodegenerative tauopathies, including Alzheimer's disease. Mutations in the tau gene lead to distinct tau filaments and deposits, highlighting tau's central role in these devastating conditions.
Area of Science:
- Neuroscience
- Genetics
- Cell Biology
Background:
- Tau is a microtubule-associated protein crucial for neuronal function.
- Abnormal tau aggregation forms filamentous deposits, a hallmark of tauopathies like Alzheimer's disease.
Purpose of the Study:
- To investigate the role of tau gene mutations in familial frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17).
- To understand how tau mutations contribute to neurodegeneration and tau pathology.
Main Methods:
- Genetic analysis of tau gene mutations in FTDP-17 patients.
- Characterization of tau filament morphology and composition in disease models.
Main Results:
- Tau gene mutations identified in familial dementia cases.
- Mutations result in tau filaments with altered morphology and distinct tau isoform composition.
- These distinct tau deposits mirror pathology seen in sporadic tauopathies.
Conclusions:
- Tau dysfunction is a key driver of neurodegeneration in both familial and sporadic tauopathies.
- Understanding tau mutation mechanisms is critical for deciphering neurodegenerative pathways.
- Tau pathology, irrespective of origin, underscores the protein's central role in disease.
Related Concept Videos
01:22Dementia l: Introduction
Dementia is an acquired, progressive syndrome characterized by a decline in multiple cognitive domains severe enough to impair daily functioning and reduce independence. Although memory loss is a central feature, the diagnosis requires additional deficits involving language, executive function, visuospatial skills, judgment, calculation, or abstract reasoning. These cognitive impairments reflect underlying neurodegenerative or vascular processes that gradually disrupt neuronal networks...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:26Alzheimer's Disease: Overview
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ and tau...
01:30Dementia
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual.
The progression of dementia is generally gradual.
01:29Alzheimer Disease l: Introduction
Alzheimer disease is a chronic, progressive, and irreversible neurodegenerative disorder and the most common cause of dementia in older adults. It leads to gradual neuronal loss, causing cognitive decline, behavioral changes, and loss of functional independence.Risk Factors and EtiologyThe disease is multifactorial. Age is the strongest risk factor, with prevalence doubling every 5 years after age 65. Genetic factors include mutations in genes such as APP, PSEN1, and PSEN2, which are associated...
01:22Alzheimer's Disease: Treatment
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...